
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Lijun Chen, Jingjing Qu, Farhin Shaheed Kalyani, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
Song Zhidu, Tao Ying, Rui Jiang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
Song Zhidu, Tao Ying, Rui Jiang, et al.
Stem Cell Research & Therapy (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 23
The lung mesenchyme in development, regeneration, and fibrosis
Elie El Agha, Victor J. Thannickal
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 29
Elie El Agha, Victor J. Thannickal
Journal of Clinical Investigation (2023) Vol. 133, Iss. 14
Open Access | Times Cited: 29
Key Role of Mesenchymal Stromal Cell Interaction with Macrophages in Promoting Repair of Lung Injury
Mirjana Jerkić, Katalin Szászi, John G. Laffey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3376-3376
Open Access | Times Cited: 25
Mirjana Jerkić, Katalin Szászi, John G. Laffey, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3376-3376
Open Access | Times Cited: 25
Nintedanib-loaded exosomes from adipose-derived stem cells inhibit pulmonary fibrosis induced by bleomycin
Liyun Cai, Jie Wang, Yi Xue, et al.
Pediatric Research (2024) Vol. 95, Iss. 6, pp. 1543-1552
Closed Access | Times Cited: 8
Liyun Cai, Jie Wang, Yi Xue, et al.
Pediatric Research (2024) Vol. 95, Iss. 6, pp. 1543-1552
Closed Access | Times Cited: 8
Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
Ziwei Hu, Wei Wang, Ying Lin, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 7
Ziwei Hu, Wei Wang, Ying Lin, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 7
Therapeutic utility of human umbilical cord-derived mesenchymal stem cells-based approaches in pulmonary diseases: Recent advancements and prospects
Min Meng, Weiwei Zhang, Shuangfeng Chen, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 2, pp. 70-88
Open Access | Times Cited: 6
Min Meng, Weiwei Zhang, Shuangfeng Chen, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 2, pp. 70-88
Open Access | Times Cited: 6
Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19
Mohsen Ghiasi, Peyman Kheirandish Zarandi, Abdolreza Dayani, et al.
Regenerative Therapy (2024) Vol. 27, pp. 319-328
Open Access | Times Cited: 6
Mohsen Ghiasi, Peyman Kheirandish Zarandi, Abdolreza Dayani, et al.
Regenerative Therapy (2024) Vol. 27, pp. 319-328
Open Access | Times Cited: 6
Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2022) Vol. 10, Iss. 10, pp. 1691-1691
Open Access | Times Cited: 14
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2022) Vol. 10, Iss. 10, pp. 1691-1691
Open Access | Times Cited: 14
Localized immunomodulation technologies to enable cellular and organoid transplantation
Amanda Nash, Nienke Lokhorst, Omid Veiseh
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 635-645
Open Access | Times Cited: 8
Amanda Nash, Nienke Lokhorst, Omid Veiseh
Trends in Molecular Medicine (2023) Vol. 29, Iss. 8, pp. 635-645
Open Access | Times Cited: 8
Mesenchymal Stem Cells in the Treatment of COVID-19
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14800-14800
Open Access | Times Cited: 8
Bei-Cyuan Guo, Kang‐Hsi Wu, Chun‐Yu Chen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14800-14800
Open Access | Times Cited: 8
Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
Yuyin Fang, Peizhen Lao, Long‐Qian Tang, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 7
Yuyin Fang, Peizhen Lao, Long‐Qian Tang, et al.
Cell Transplantation (2023) Vol. 32
Open Access | Times Cited: 7
Application of mesenchymal stem cells for anti-senescence and clinical challenges
Yaping Wang, Tianyun Gao, Bin Wang
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Yaping Wang, Tianyun Gao, Bin Wang
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis
Giulia Gazzaniga, M Voltini, Alessandro Carletti, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Giulia Gazzaniga, M Voltini, Alessandro Carletti, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment
Yuling Huang, Xin Li, Lina Yang
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Yuling Huang, Xin Li, Lina Yang
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Danyi Li, Wenjie Cao, Qun Zhou, et al.
International Wound Journal (2023) Vol. 20, Iss. 10, pp. 4422-4428
Open Access | Times Cited: 6
Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19
Jitendra Kumar Chaudhary, Deepika Saini, Pankaj Kumar Chaudhary, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2175-2175
Open Access | Times Cited: 9
Jitendra Kumar Chaudhary, Deepika Saini, Pankaj Kumar Chaudhary, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2175-2175
Open Access | Times Cited: 9
Focusing on the cytokine storm in the battle against COVID-19: the rising role of mesenchymal-derived stem cells
Abdul Naeem, Arshi Waseem, Abu Junaid Siddiqui, et al.
Elsevier eBooks (2024), pp. 191-207
Closed Access | Times Cited: 1
Abdul Naeem, Arshi Waseem, Abu Junaid Siddiqui, et al.
Elsevier eBooks (2024), pp. 191-207
Closed Access | Times Cited: 1
Strengthening pharmacotherapy research for COVID-19-induced pulmonary fibrosis
Yan-Miao Liu, Jing Zhang, Jingjing Wu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 5, pp. 875-879
Open Access | Times Cited: 1
Yan-Miao Liu, Jing Zhang, Jingjing Wu, et al.
World Journal of Clinical Cases (2024) Vol. 12, Iss. 5, pp. 875-879
Open Access | Times Cited: 1
The Main Mechanisms of Mesenchymal Stem Cell-Based Treatments against COVID-19
Jinling Li, Shipei He, Hang Yang, et al.
Tissue Engineering and Regenerative Medicine (2024) Vol. 21, Iss. 4, pp. 545-556
Closed Access | Times Cited: 1
Jinling Li, Shipei He, Hang Yang, et al.
Tissue Engineering and Regenerative Medicine (2024) Vol. 21, Iss. 4, pp. 545-556
Closed Access | Times Cited: 1
Mesenchymal Stem Cell-derived Type II Alveolar Epithelial Progenitor Cells Attenuate LPS-induced Acute Lung Injury and Reduce P63 Expression
Ning Ma, Mengwei Zhang, Guofeng Xu, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 2, pp. 245-256
Closed Access | Times Cited: 3
Ning Ma, Mengwei Zhang, Guofeng Xu, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 2, pp. 245-256
Closed Access | Times Cited: 3
Inorganic nanoparticle‐integrated mesenchymal stem cells: A potential biological agent for multifaceted applications
Juanjuan Zheng, Xinchi Jiang, Yaosheng Li, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 3
Juanjuan Zheng, Xinchi Jiang, Yaosheng Li, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 3
Clinical Trials of Mesenchymal Stem Cells for the Treatment of COVID 19
Elham Zendedel, Lobat Tayebi, Mohammad Reza Nikbakht, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 8, pp. 1055-1071
Closed Access | Times Cited: 3
Elham Zendedel, Lobat Tayebi, Mohammad Reza Nikbakht, et al.
Current Stem Cell Research & Therapy (2023) Vol. 19, Iss. 8, pp. 1055-1071
Closed Access | Times Cited: 3
Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
Nedelcho Ivanov, Boris Krastev, Dimitrina Miteva, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 9, pp. 343-356
Open Access | Times Cited: 2
Nedelcho Ivanov, Boris Krastev, Dimitrina Miteva, et al.
World Journal of Clinical Oncology (2023) Vol. 14, Iss. 9, pp. 343-356
Open Access | Times Cited: 2
Implications of stem cell therapy on the socio-scientific community
Suja Ann Mathew
Elsevier eBooks (2024), pp. 387-394
Closed Access
Suja Ann Mathew
Elsevier eBooks (2024), pp. 387-394
Closed Access